scholarly journals Fibrin sheaths in central venous port catheters: treatment with low-dose, single injection of urokinase on an outpatient basis

2017 ◽  
Vol Volume 13 ◽  
pp. 111-115 ◽  
Author(s):  
De-Hua Chang ◽  
Kamal Mammadov ◽  
Tilman Hickethier ◽  
Jan Borggrefe ◽  
Martin Hellmich ◽  
...  
Perfusion ◽  
2017 ◽  
Vol 33 (5) ◽  
pp. 404-406
Author(s):  
Yen-Hsiang Wang ◽  
Chieh-Shou Su ◽  
Keng-Hao Chang ◽  
Chi-Jen Went ◽  
Wen-Lieng Lee ◽  
...  

The use of central venous port access is increasing due to the requirements of multimodal intravenous therapy.1 However, catheter malposition in smaller veins can lead to vein thrombosis, phlebitis and pain. Herein, we report our experience with the use of percutaneous interventions to correct migrated port catheter malposition. Minimally invasive percutaneous interventional correction of malposition could be an alternative to extraction and re-implantation of malpositioned port catheters.


2017 ◽  
Vol 58 (12) ◽  
pp. 1468-1475 ◽  
Author(s):  
Roman Rotzinger ◽  
Bernhard Gebauer ◽  
Dirk Schnapauff ◽  
Florian Streitparth ◽  
Gero Wieners ◽  
...  

Background Placement of central venous port catheters (CVPS) and peripherally inserted central catheters (PICC) is an integral component of state-of-the-art patient care. In the era of increasing cost awareness, it is desirable to have more information to comprehensively assess both procedures. Purpose To perform a retrospective analysis of interventional radiologic implantation of CVPS and PICC lines in a large patient population including a cost analysis of both methods as well as an investigation the learning curve in terms of the interventions’ durations. Material and Methods All CVPS and PICC line related interventions performed in an interventional radiology department during a three-year period from January 2011 to December 2013 were examined. Documented patient data included sex, venous access site, and indication for CVPS or PICC placement. A cost analysis including intervention times was performed based on the prorated costs of equipment use, staff costs, and expenditures for disposables. The decrease in intervention duration in the course of time conformed to the learning curve. Results In total, 2987 interventions were performed by 16 radiologists: 1777 CVPS and 791 PICC lines. An average implantation took 22.5 ± 0.6 min (CVPS) and 10.1 ± 0.9 min (PICC lines). For CVPS, this average time was achieved by seven radiologists newly learning the procedures after performing 20 CVPS implantations. Total costs per implantation were €242 (CVPS) and €201 (PICC lines). Conclusion Interventional radiologic implantations of CVPS and PICC lines are well-established procedures, easy to learn by residents, and can be implanted at low costs.


2012 ◽  
Vol 73 (11) ◽  
pp. 2741-2744
Author(s):  
Naoki HASHIZUME ◽  
Hirotsugu TERAKURA ◽  
Kazuhiko YOSHIMOTO

2018 ◽  
Vol 36 (4_suppl) ◽  
pp. 589-589
Author(s):  
Tetsuhito Muranaka ◽  
Yoshito Komatsu ◽  
Masataka Yagisawa ◽  
Yasuyuki Kawamoto ◽  
Hiroshi Nakatsumi ◽  
...  

589 Background: Totally implantable central venous port systems (TICVP) are easy to implant on an in- or outpatient basis and provide reliable, long-lasting central venous access for treatment of intravenous anti-cancer chemotherapy in patients with cancer but it is needed to cut 3cm of patients’ skin at the operation. Bevacizumab is one of the anti vascular endothelial growth factor (ant-VEGF) antibody which is known to improve overall survival in patients with colorectal cancer but have a side effect of delayed wound healing. There are few reports about the safety of administration of bevacizumab in a short period of time from the small surgery such as placement of TICVP. Methods: Patients who were placed TICVP in Department of Gastroenterology of Hokkaido University Hospital from July 2009 to December 2016. We planned to compare the rate of post-operative wound dehiscence (POWD) and surgical site infection (SSI) between patients who administered bevacizumab within a week from placement of TICVP (Group A) and the other patients (Group B). Patients who didn’t receive any chemotherapy after placement of TICVP were excluded. Results: We found 432 patients who implanted TICVP, and excluded 32 patients who didn’t receive any chemotherapy. 50 patients were assigned to Group A and 350 patients were assigned to Group B. Median age in both group were 67.5 in Group A and 65 in Group B. The averages of operation time were 38.7 (+/-19.3) minutes in Group A and 36.4 (+/-19.5) minutes in Group B. Prophylactic antibiotics were given to 27 patients (54%) in Group A and 146 patients (48.7%) in Group B. The rate of POWD was 0.0% (0/50) in Group A vs 1.1% (4/350) in Group B ( p = 0.45 ) , and the rate of SSI was 0.0%(0/50) in Group A vs 1.1% (4/350) in Group B ( p = 0.45 ) . The average of operation time of patients with and without POWD was 56.4 minutes and 36.7 minutes (p = 0.013). Conclusions: In our study, it was found that there is no significant increase of incidence by administration of bevacizumab within a short period from placement of TICVP. The long operation time tends to increase the rate of POWD.


2010 ◽  
Vol 11 (4) ◽  
pp. 335-341 ◽  
Author(s):  
Ulf K.M. Teichgräber ◽  
Sebastian N. Nagel ◽  
Stephan Kausche ◽  
Florian Streitparth ◽  
Chie Hee Cho

2020 ◽  
Vol 189 (4) ◽  
pp. 1371-1377
Author(s):  
Mehmet Emin Ince ◽  
Gökhan Ozkan ◽  
Nadide Ors ◽  
Alperen Kutay Yildirim ◽  
Suat Doganci

2014 ◽  
Vol 25 (3) ◽  
pp. S173
Author(s):  
M. Zahra ◽  
G. Krishnamurthy ◽  
M.S. Keller ◽  
A. McIntosh ◽  
A. Cahill ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document